Skip to main content
Christine Chung, MD, Oncology, Tampa, FL

Christine Hwayong Chung MD

Oncology•Tampa, FL

Head & Neck Cancer, Hematologic Oncology

Senior Member and Chair, Department of Head and Neck-Endocrine Oncology, Moffitt Cancer Center

Request Appointment

  • 12902 Magnolia Dr.Tampa, FL 33612

  • Book by Phone+1(858) 956-1424

  • Fax+1 813-745-7229

Overview of  Dr. Chung

Dr. Christine Chung is an oncologist in Tampa, FL and is affiliated with H. Lee Moffitt Cancer Center and Research Institute. She received her medical degree from Eastern Virginia Medical School and has been in practice 28 years. Dr. Chung accepts several types of health insurance, listed below. She is one of 199 doctors at H. Lee Moffitt Cancer Center and Research Institute who specialize in Oncology. She also speaks multiple languages, including Korean. She has more than 100 publications and over 500 citings.

Education & Training

  • University of North Carolina Hospitals
    University of North Carolina HospitalsFellowship, Hematology and Medical Oncology, 2000 - 2003
  • University of North Carolina Hospitals
    University of North Carolina HospitalsResidency, Internal Medicine, 1998 - 2001
  • Eastern Virginia Medical School
    Eastern Virginia Medical SchoolClass of 1998
  • Johns Hopkins University
    Johns Hopkins UniversityMS, Interdisciplinary Science Studies, 1992 - 1994
  • University of California, Los Angeles
    University of California, Los AngelesBS, Biochemistry, 1987 - 1991

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2015 - 2027
  • MD State Medical License
    MD State Medical License 2010 - 2016
  • TN State Medical License
    TN State Medical License 2003 - 2010
  • NC State Medical License
    NC State Medical License 1999 - 2004
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2014, 2016-2017
  • CMS Meaningful Use Stage 2 Certification FairWarning® Patient Privacy Monitoring, FairWarning Technologies, LLC, 2014, 2016-2017
  • CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Integrated Time Course Omics Analysis Distinguishes Immediate Therapeutic Response from Acquired Resistance  
    Joseph A Califano, Christine H Chung, BioMed Central
  • A retrospective analysis of cross-reacting cetuximab IgE antibody and its association with severe infusion reaction  
    Maier S, Chung CH, Morse M, Platts-Mills T, Townes L, Mukhopadhyay P, Bhagavatheeswaran P, Racenberg J, Trifan OC, Cancer Medicine, 1/1/2015
  • Cleaved NOTCH1 expression pattern in head and neck squamous cell carcinoma is associated with NOTCH1 mutation, HPV status and high-risk clinical features  
    Rettig EM, Chung CH, Bishop JA, Howard JD, Sharma RB, Li RJ, Douville C, Karchin R, Izumchenko E, Sidransky D, Koch W, Califano J, Agrawal N, Fakhry C, Cancer Prev Res, 1/1/2015

Books/Book Chapters

  • Molecular Targets of Head and Neck Cancer. Current Cancer Research 
    Chapter: Chapter 7-The PI3K signaling pathway in head and neck squamous cell carcinoma. 
    Page 131 - 161Howard J, Chung CHSpringer, New York, NY2014
  • Head and Neck Cancer: A Multidisciplinary Approach 
    Chapter: Chapter 16: Cancer of the Oral Cavity: General Principles and Management. 
    Koch WM, Stafford E, Chung CH, Quon HWolters Kluwer Health--Lippincott Williams & Wilkins2014
  • Textbook of Uncommon Cancer 
    Chapter: Chapter 9: Esthesioneuroblastoma. 
    Page 133 - 142Murphy BA, Aulino JM, Chung CH, Ely K, Sinard R, Cmelak AJohn Wiley & Sons, Ltd.Edition 3rd,2006

Lectures

  • Ready for a Molecular Signature as a Prognostic/Predictive Biomarker? 
    Milan, Italy - 1/24/2014
  • What is the current and future role of systemic therapy in the TOS-treated patients? 
    Baltimore, MD - 1/24/2014
  • Benefits of genomic medicine: what to tell the patient. 
    Boston, MA - 1/14/2014

Other

  • Supportive care for patients with head and neck cancer. Medscape Hematology-Oncology. 
    Murphy BA, Chung CH, Medscape, LLC
    1/1/2006

Press Mentions

  • Moffitt to Unveil Plenary and Late-Breaking Findings on Blood, Melanoma, and Brain Metastases at ASCO 2025
    Moffitt to Unveil Plenary and Late-Breaking Findings on Blood, Melanoma, and Brain Metastases at ASCO 2025May 22nd, 2025
  • Cue Biopharma Presents Positive Data Update from Ongoing Phase 1 Trials of CUE-101 for Recurrent/Metastatic HPV+ Head and Neck Squamous Cell Carcinoma at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
    Cue Biopharma Presents Positive Data Update from Ongoing Phase 1 Trials of CUE-101 for Recurrent/Metastatic HPV+ Head and Neck Squamous Cell Carcinoma at the 2023 American Society of Clinical Oncology (ASCO) Annual MeetingMay 25th, 2023
  • Saliva HPV Test Ready for Prime Time in Head and Neck Cancer?
    Saliva HPV Test Ready for Prime Time in Head and Neck Cancer?March 28th, 2019

Other Languages

  • Korean

External Links

  • Moffitt Cancer Centerhttp://https://www.moffitt.org/providers/Christine-Chung?specialty=Head%20and%20Neck

Insurance Accepted

  • BCBS Blue Card PPO
    CareFirst BCBS Maryland POS
    CareFirst BlueChoice Advantage
    CareFirst BlueChoice Network POS
    CareFirst BluePreferred PPO
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Great West PPO
    Multiplan PHCS PPO
    Multiplan PPO
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Christine Chung, Dr. Christine Chung, MD, Dr. C Chung, Dr. Christine Hwayong Chung